MIDDLE EAST PHARMACEUTICAL INDUSTRIES COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 127 SAR | -0.78% |
|
-4.80% | 0.00% |
| 05-19 | Avalon Pharma Swings to Profit in Q1; Revenue Down | MT |
| 05-06 | Avalon Pharma Secures Regulatory Nod for Second Production Facility in Saudi Arabia | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 683M | - | - | - | - | ||
| 41.97B | ||||||
| 22.34B | ||||||
| 15.25B | ||||||
| 14B | ||||||
| 12.06B |
